100% Veteran Owned & Operated
Alpha 1 Labs
ALPHA 1 LABS
Veteran-Owned • U.S. pharmacy-compounded

A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.

TB-500 (Thymosin Beta-4) Clinical Protocol
Veteran Owned • U.S. pharmacy-compounded
Advanced Peptide

TB-500 (Thymosin Beta-4)

Investigational Actin-Binding Peptide Fragment

Immune & DefenseImmune defense and antioxidant support
Direct Door Delivery
Doctor Consult Required
Alpha 1 Labs TB-500 Clinical Vial
Compounded Preparation> 99% Purity • 3mL (Injectable)

Compound Specifications

FormatInjectable
StorageRefrigerate at 36°F - 46°F.
Fulfillment 100% Shipped Direct
OriginU.S. pharmacy-compounded
Advanced Peptide•USA Veteran Owned

TB-500 (Thymosin Beta-4)

Investigational Actin-Binding Peptide Fragment

TB-500 10mg in a 3mL vial is a synthetic peptide containing the active domain of Thymosin Beta-4, a naturally occurring protein studied in preclinical models for its involvement in cellular motility, actin regulation, and experimental tissue repair pathways.

Clinical Mechanism of Action

In laboratory research, Thymosin Beta-4 active domain has been observed to bind actin, potentially supporting cell migration, endothelial cell organization, and localized tissue repair responses.

Documented Therapeutic Benefits

Concentrated 10mg presentation for intensive cellular motility and soft-tissue recovery
Studied in animal and cellular models for support of connective tissue remodeling
May help support recovery protocols when combined with physical conditioning under medical guidance
Formulated by licensed compounding pharmacy partners pursuant to prescription

Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.

Clinical Administration Protocol

Subcutaneous administration 2 times weekly during recovery cycles.

Door Delivery Only: We do not offer in-clinic pickup. All medications are dispatched directly to your residential address in cold-chain packaging.

Frequently Asked Clinical Questions

How does TB-500 differ from BPC-157?

Preclinical literature evaluates TB-500 for cellular migration and actin-binding pathways, whereas BPC-157 is primarily studied for microvascular and cytoprotective mechanisms.